Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-08-07
2007-08-07
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
active
11364659
ABSTRACT:
Compositions containing β2adrenergic agonists in combination with carbonates and carbamates of the formulaand in combination with related steroid carbonates and carbamates are disclosed. The compositions are useful for treating bronchospasm, for inducing bronchodilation and for treating rhinitis, asthma, and chronic obstructive pulmonary disease (COPD) and inflammatory diseases, particularly by inhalation.
REFERENCES:
patent: 3056727 (1962-10-01), Allais et al.
patent: 3329570 (1967-07-01), Lilas et al.
patent: 4235887 (1980-11-01), Voorhees et al.
patent: 5681964 (1997-10-01), Ashton et al.
patent: 19541689 (1996-05-01), None
patent: 126929 (1972-04-01), None
patent: 1269291 (1972-04-01), None
patent: WO92/13873 (1992-08-01), None
patent: WO93/11773 (1993-06-01), None
patent: WO 93/11773 (1993-06-01), None
patent: WO95/20567 (1995-08-01), None
patent: WO 01/78742 (2001-10-01), None
patent: WO01/78742 (2001-10-01), None
patent: 2WO03/070745 (2003-08-01), None
Csaky, Cutting's Handbook of pharmacology, 6th Edition, pp. 351-358, 1979.
Stedman's Medical Dictionary, 27th Edition.
XP008009269; Creticos et al., “Comparison of Triamcinolone Acetonide (TAA), Salmeterol Xinofate (SMT), TAA + SMT, and Placebo (PL) in Mild—Moderate Asthmatics,”European Respiratory Journal,12 (28), 1565 (1998).
XP001013661; McGavin et al., “Inhaled Budesonide/Formoterol Combination,”Drugs61, 71-78 (2001).
Charpiot et al. “Disease activated Drugs: A New Concept. for the Treatment of Asthma”Biorg. Med. Chem.9, 1793-1805 (2001).
El Masry et al. “Snythesis and Biological Action of Two Glucocorticoid Alkylating Agents”J. Med. Chem. 20, 1134-1139 (1977).
Lange et al. “Soluble Steroids I Sugar Derivatives”J. Pharm. Sci. 51, 1102-1106 (1962).
Brown et al. “Some 21-Carbamates of Hydrocortisone and Related Compounds”J. Org. Chem. 27, 961-963 (1962).
Currie Mark G.
Fang Q. Kevin
Grover Paul
Jones Steve
Senanayake Chris H.
Badio Barbara P.
Hansen Philip E.
Heslin Rothenberg Farley & & Mesiti P.C.
Senska, Esq. Erika J.
Sepracor Inc.
LandOfFree
Carbonate and carbamate modified forms of glucocorticoids in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbonate and carbamate modified forms of glucocorticoids in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbonate and carbamate modified forms of glucocorticoids in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3875393